ArticleInternational journal of molecular sciences2023

A Novel Probiotic-Based Oral Vaccine against SARS-CoV-2 Omicron Variant B.1.1.529.

Eddie Chung Ting Chau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.